Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
Patents for C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
11/2003
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/04/2003US6642245 Treatment of HIV and HBV infections in humans
11/04/2003CA2188283C Substituted 1,3-oxathiolanes with antiviral properties
10/2003
10/28/2003CA2105486C Therapeutic nucleosides
10/23/2003WO2003087073A1 Estrogen receptor modulators
10/23/2003WO2003086388A1 Estrogen receptor modulators
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
10/15/2003EP0973747B1 Pesticidal 1-arylpyrazoles
10/02/2003US20030187020 Chemical compounds
10/01/2003EP1200423B1 Substituted phenyl uracils
09/2003
09/25/2003US20030181458 Preferential serotonin receptors antagonists comprising heterocyclic amines used for prophylaxis or prevention of headaches, sleep, sexual or eating disorders and as antidepressants
09/18/2003WO2002102796A8 Stereoselective method for the preparation of nucleoside analogues
09/18/2003US20030176400 For therapy of allergic diseases such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis
09/17/2003EP1343779A2 Novel compounds
09/16/2003CA2232116C Novel n-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2231025C Novel compounds of 2-aminoindane, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2037575C N-(4-piperidinyl) (dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives
09/12/2003WO2003074491A1 O-cyclopropyl-carboxanilides and their use as fungicides
09/11/2003US20030170771 Compounds for generating chemiluminescence with a peroxidase
09/11/2003US20030170762 Compounds for generating chemiluminescence with a peroxidase
09/10/2003CN1120840C Preparation method of lamifudin
09/04/2003US20030164173 Reduced ignition propensity smoking article
09/03/2003EP1070065B1 Azabicyclic 5ht1 receptor ligands
08/2003
08/28/2003WO2003070726A1 Pyranones useful as atm inhibitors
08/28/2003WO2003070277A1 Antipruritics
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003CA2473100A1 Pyranones useful as atm inhibitors
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/21/2003WO2001029756A8 Autogrid analysis
08/21/2003US20030158150 Combination therapy to treat hepatitis B virus
08/20/2003CN1437602A Compounds for treating impaired fundic relaxation
08/13/2003EP1333827A2 Estrogen receptor modulators
08/06/2003CN1117092C Azadicyclic compound, its medicinal composition and medicinal use
07/2003
07/31/2003US20030144532 Method of manufacture of 1,3-oxathiolane nucleosides
07/31/2003US20030144507 Sulfonamide-containing heterocyclic compounds
07/29/2003US6600044 Such as cis-(-)-4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone (lamivudine, 3TC) or emtricitabine via anomerization/transglycosylation
07/23/2003EP1328522A2 Estrogen receptor modulators
07/17/2003US20030135048 Predominantly cis nucleosides or nucleoside analogues and derivatives from 2-oxymethyl- thiolane-S-oxide, oxathiolane-S-oxide or dithiolane-S-oxide and a pyridine, pyrimidine or triazine base
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/10/2003WO2003006440A8 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
07/08/2003US6589983 Antiarrhythmic agents having the prolongation effect on the functional refractory period as a main function
07/03/2003WO2003053934A1 Improved compounds for generating chemiluminescence with a peroxidase
07/03/2003WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
07/02/2003CN1427824A Indole derivatives, process for preparation of same and use thereof
06/2003
06/26/2003WO2003040109A3 Quinazoline derivatives as antitumor agents
06/25/2003EP0806957B1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc together with azt.
06/19/2003US20030114670 Process for preparing substituted pyridines
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/10/2003US6576776 Method of manufacture of 1,3-oxathiolane nucleosides
06/05/2003US20030105074 Phthalazine compounds and therapeutic agents for erectile dysfunction
05/2003
05/28/2003EP0817784B1 Process for the synthesis of nucleoside analogues
05/21/2003CN1419542A Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides 403
05/21/2003CN1418966A Resoldution method for racemic compound of nucleoside enantiomorph
05/21/2003CN1109108C Method for resolution of a racemic mixture of nucleoside enantioners
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/15/2003WO2003040139A1 Diastereoselective process for the preparation of the antiviral agent4-amino-1-(2r-hydroxymethyl-[1,3]oxathiolan-5s-yl)-1h-pyrimidin-2-one
05/15/2003WO2003040109A2 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040108A1 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465100A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2465068A1 Quinazoline derivatives as antitumor agents
05/13/2003US6562759 Substituted phenyl uracils
05/08/2003US20030087918 Substituted with purine or pyrimidine bases
05/06/2003US6559109 1,3-Oxathianes as perfuming and flavoring ingredients
04/2003
04/30/2003CN1414952A Heterocyclic compounds having sulfonic acid
04/24/2003WO2003032993A1 Use of phosphorodiesterase iv inhibitors
04/24/2003US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase
04/23/2003EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors
04/16/2003EP0674634B1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties
04/15/2003US6548532 Topically applying onto the afflicted skin and/or scalp cosmetically/ therapeutically effective amount of indolecarboxylic acid compound, or ester or salt thereof
04/03/2003WO2003027106A1 Process for the preparation of crystalline polymorph ii of lamivudine
04/03/2003WO2002039954A3 Novel compounds
04/02/2003EP1296987A1 Compounds for treating impaired fundic relaxation
04/02/2003EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors
04/02/2003CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides
04/01/2003US6541631 Forming a solution containing first and second enantiomer of cis-(5-(4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathi olan-2-yl)methyl butanoate, separating first and second enantiomer by simulated moving bed chromatography
03/2003
03/27/2003WO2003024949A1 Dna-pk inhibitors
03/27/2003US20030060645 Polymorphic and other crystalline forms cis-FTC
03/27/2003CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases
03/26/2003EP1180104B1 Methods of separating ftc isomers and derivatives thereof
03/26/2003CN1103593C Synergistic composition
03/20/2003WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
03/13/2003WO2003020302A1 Hepatitis b virus proliferation inhibitor
03/13/2003CA2458820A1 Agent for suppression of hepatitis b virus replication
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/06/2003US20030045554 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
03/04/2003US6528515 Beta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (beta -FTC) and penciclovir
02/2003
02/25/2003US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine;
02/12/2003EP0861239B1 Biphenyl ether oxazolines and their use as pest-control agents
02/12/2003CN1396833A Integrin expression inhibitors
02/11/2003US6518431 Reacting 2,5-disubstituted pyridine with silalating agent
02/11/2003US6518425 A process for producing a 1,3-oxathiolane nucleoside comprising reacting a 5-halo-2-protected-oxymethyl-1,3-oxathiolane with a silylated purine or pyrimidine without the addition of a Lewis acid or an additional base to the reaction
02/05/2003CN1100774C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
01/2003
01/30/2003US20030022905 Prevention and/or therapy of ischaemia and reperfusion damage; poly(ADP-ribose)-synthetase inhibitors
01/29/2003CN1100055C Piperazine and piperidine compounds
01/23/2003WO2003006452A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25